Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity

被引:174
作者
Kimura, Yuka [1 ]
Ito, Hideyuki [1 ]
Ohnishi, Ryoko [1 ]
Hatano, Tsutomu [1 ]
机构
[1] Okayama Univ, Div Pharmaceut Sci, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan
关键词
Amentoflavone; Apigenin; Cytochrome P450; Imperatorin; Polyphenols; ST-JOHNS-WORT; GRAPEFRUIT JUICE; DRUG-INTERACTIONS; GINKGO-BILOBA; WARFARIN; PHARMACODYNAMICS; PHARMACOKINETICS; IDENTIFICATION; FLAVONOIDS; COMPONENTS;
D O I
10.1016/j.fct.2009.10.041
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Polyphenols present in foods and supplements may contribute to human health by preventing cardiovascular diseases and cancer. Drug-food or drug-herb interactions have recently come into focus but, except for some phytochemicals, few components of food or herbs participate in such interactions. In this study, we systematically evaluated the inhibitory effects of 60 polyphenols and related compounds on human cytochrome P450 (CYP) 3A4 and CYP2C9 activity by in vitro assay to investigate whether some polyphenols induce drug interactions. In addition, the kinetics of potent CYP inhibitors was investigated by Lineweaver-Burk plot analysis. Three coumarins and 12 flavonoids significantly suppressed CYP3A4 or CYP2C9 activities. Lineweaver-Burk plot analysis indicated that apigenin and its dimer amentoflavone and imperatorin displayed a mixed type of inhibition on CYP3A4 or CYP2C9. Among the inhibitors, amentoflavone was the most potent inhibitor of CYP3A4 and CYP2C9 activities with IC50 values of 0.07 and 0.03 mu M, respectively. The K-i value of amentoflavone was significantly lower than that of the CYP2C9 inhibition positive control sulfaphenazole. These findings suggest that some dietary polyphenols may have the potential to inhibit the metabolism of clinical drugs. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:429 / 435
页数:7
相关论文
共 26 条
[1]  
Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S
[2]   Grapefruit juice-drug interactions [J].
Bailey, DG ;
Malcolm, J ;
Arnold, O ;
Spence, JD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (02) :101-110
[3]   Evidence-based drug-herbal interactions [J].
Chavez, ML ;
Jordan, MA ;
Chavez, PI .
LIFE SCIENCES, 2006, 78 (18) :2146-2157
[4]  
Cvetkovic M, 1999, DRUG METAB DISPOS, V27, P866
[5]   Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B [J].
Fuchikami, H ;
Satoh, H ;
Tsujimoto, M ;
Ohdo, S ;
Ohtani, H ;
Sawada, Y .
DRUG METABOLISM AND DISPOSITION, 2006, 34 (04) :577-582
[6]   Drug interactions with grapefruit juice - Extent, probable mechanism and clinical relevance [J].
Fuhr, U .
DRUG SAFETY, 1998, 18 (04) :251-272
[7]   Ginkgo biloba does not alter clearance of flurbiprofen, a cytochrome P450-2C9 substrate [J].
Greenblatt, DJ ;
von Moltke, LL ;
Luo, Y ;
Perloff, ES ;
Horan, KA ;
Bruce, A ;
Reynolds, RC ;
Harmatz, JS ;
Avula, B ;
Khan, IA ;
Goldman, P .
JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (02) :214-221
[8]  
Gutteridge J.M.C., 1994, ANTIOXIDANTS NUTR HL
[9]   Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450 [J].
Hodek, P ;
Trefil, P ;
Stiborová, M .
CHEMICO-BIOLOGICAL INTERACTIONS, 2002, 139 (01) :1-21
[10]   Identification and characterization of potent CYP3A4 inhibitors in Schisandra fruit extract [J].
Iwata, H ;
Tezuka, Y ;
Kadota, S ;
Hiratsuka, A ;
Watabe, T .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (12) :1351-1358